FindTrial
Sign In

An Open Label, Prospective, Uncontrolled Clinical Trial to Study The Effectiveness of Homeopathic Treatment in Management of Uterine Fibroids Through Bogers Concept of Totality.

TO STUDY EFFECTIVENESS OF HOMOEOPATHIC TREATMENT IN MANAGEMENT OF UTERINE FIBROIDS THROUGH BOGERS CONCEPT OF TOTALITY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053796
Enrollment
30
Registered
2023-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D259- Leiomyoma of uterus, unspecified

Interventions

Intervention1: Administration of Homoeopathic Medicines according to Homoeopathic Indivisualization after complete case taking.: After obtaining consent and asked all questions in case performa medici

Sponsors

NEHRU HOMEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Well diagnosed case of uterine fibroid on the basis of clinical signs and symptoms along with Ultrasonography 2. Female Patients with age group of 20-50 yrs of age 3. Those who agree to give consent to participate in the study 4. Uterine fibroid of size

Exclusion criteria

Exclusion criteria: 1. Patients with complications of uterine fibroids 2. Substance abuse or dependence. 3. Patients of malignancy 4. Patients who are terminally ill, under immunosuppressive treatment or self-reported immunocompromised state. 5. Diagnosed case of mental illness / psychiatric/ other uncontrolled/ life threatening illness affecting quality of life/any organ failure. 6. Patient unable to comply with the study protocol (including psychiatric diseases). 7. Pregnant ladies are excluded. 8. Unwilling to take part and not giving consent to join the study

Design outcomes

Primary

MeasureTime frame
UTERINE FIBROID SYMPTOM- HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRE (UFS-QOL)Timepoint: ONE AT THE BASELINE, IN 6 MONTHS AND IN END OF STUDY( 1 YEAR)—

Secondary

MeasureTime frame
MONARCH SCALETimepoint: EVERY 4 WEEKS UPTO 1 YEAR—

Countries

India

Contacts

Public ContactTWINKLE BHARTI

NEHRU HOMEOPATHIC MEDICAL COLLEGE AND HOSPITAL

rashmichowdhry62@gmail.com8076050166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026